|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.7 USD | -0.23% |
|
+1.06% | -6.68% |
| 15/07 | Equity Markets Higher After Fed Chair Powell's Comments | MT |
| 15/07 | Equity Markets Rise Intraday After Fed Chair Powell's Comments | MT |
Abbott Laboratories reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 40,109 million compared to USD 43,653 million a year ago. Net income was USD 5,723 million compared to USD 6,933 million a year ago.
Diluted earnings per share from continuing operations was USD 3.26 compared to USD 3.91 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.68% | 179B | |
| -5.20% | 98.84B | |
| -5.38% | 65.34B | |
| +15.46% | 45.41B | |
| -6.47% | 44.94B | |
| +9.74% | 43.76B | |
| +14.01% | 29.01B | |
| +19.39% | 25.65B | |
| -6.53% | 23.32B | |
| -11.70% | 21.92B |
ABBOTT LABORATORIES 
